Zosano Pharma CEO passes baton down to successor; James Sapirstein takes the helm at AzurRx
→ Two years after Zosano Pharma reported positive Phase III data for its microneedle patch system for delivering an old migraine …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.